Onderzoeker
Jolien De Bie
- Disciplines:Systeembiologie
Affiliaties
- Laboratorium voor Moleculaire Biologie van Leukemie (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 aug 2014 → 31 jul 2018
Projecten
1 - 2 of 2
- Optische Genoom Mapping en long-read sequencing in lymfomenVanaf1 sep 2023 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Moleculaire analyse van individuele leukemiecellen bij acute lymfatische leukemieVanaf1 aug 2014 → 30 sep 2018Financiering: FWO mandaten
Publicaties
1 - 10 van 14
- Clonal Heterogeneity and Evolution during Treatment in High Hyperdiploid B-Cell Acute Lymphoblastic Leukemia(2023)
Auteurs: Margo Aertgeerts, Jolien De Bie, Heidi Segers
- Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion(2023)
Auteurs: Quentin Van Thillo, Barbara Dewaele, Jolien De Bie, Lucienne Michaux, Timothy Devos, Peter Vandenberghe
Pagina's: E7 - E10 - Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping(2022)
Auteurs: Jolien De Bie, Sofie Demeyer, Jan Cools, Kim De Keersmaecker, Joris Vermeesch, Johan Maertens, Heidi Segers, Lucienne Michaux, Barbara Dewaele
Pagina's: 548 - 561 - Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing(2022)
Auteurs: Sarah Meyers, Jolien De Bie, Lucienne Michaux, Barbara Dewaele, Nancy Boeckx, Anne Uyttebroeck, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools, et al.
- Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia(2021)
Auteurs: Quentin Van Thillo, Jolien De Bie, Sofie Demeyer, Heidi Segers, Nancy Boeckx, Anne Uyttebroeck, Jan Cools
- Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia(2021)
Auteurs: Sofie Demeyer, Inge Govaerts, Jolien De Bie, Lucienne Michaux, Johan Maertens, Anne Uyttebroeck, Kim De Keersmaecker, Nancy Boeckx, Heidi Segers, Jan Cools
Pagina's: 801 - 811 - The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia(2020)
Auteurs: Delphine Verbeke, Sofie Demeyer, Jolien De Bie, Anne Uyttebroeck, Nancy Boeckx, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools
Pagina's: 5747 - 5758 - Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia(2018)
Auteurs: Marlies Vanden Bempt, Sofie Demeyer, Michaël Broux, Jolien De Bie, Simon Bornschein, Ellen Geerdens, Charles De Bock, Jan Cools
Pagina's: 271 - + - Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia(2018)
Auteurs: Jolien De Bie, Sofie Demeyer, Ellen Geerdens, Heidi Segers, Michaël Broux, Kim De Keersmaecker, Lucienne Michaux, Peter Vandenberghe, Thierry Voet, Nancy Boeckx, et al.
Pagina's: 1358 - 1369 - BCR-ABL1 positive B-ALL can undergo T-cell lineage shift to become CD19 negative T-ALL(2018)
Auteurs: Jolien De Bie, Sofie Demeyer, Heidi Segers, Lucienne Michaux, Peter Vandenberghe, Nancy Boeckx, Anne Uyttebroeck, Jan Cools